Entities / Company
Novocure (Jersey).
company in Saint Helier, Jersey
- Reports this week
- 0
- Active events
- 0
- Connections
- 34
What's happening
Gone quiet
No new reports in 90+ days-
Novocure established its global headquarters in Baar, Switzerland, and maintains research and development facilities in Haifa, Israel. The company also uses LinkedIn and Twitter for updates.Some support3 reports
-
Novocure's stock price was boosted by strong market conditions on June 30, 2025.Speculative1 report
-
Leerink partners reiterated a Buy rating on Novocure Limited, citing solid results regarding its Optune/TTFields therapy.Some support2 reports
-
Novocure submitted a PMA application for its proprietary TTFields therapy, Optune Lua, targeting pancreatic cancer.Some support2 reports
-
Novocure announced coverage in Spain, appointing a country manager and gaining availability through the Spanish Ministry of Health.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Novocure (Jersey) this week
News at the entities that move Novocure (Jersey) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Novocure (Jersey)
-
Switzerland Shared contextECB has established swap line arrangements with central banks, with the ECB President leading central bank operations.Moves Novocure (Jersey)
-
Haifa Shared contextAvi Nesher received a lifetime achievement award at a festival on September 1, 2026.Moves Novocure (Jersey)
-
Twitter Mentioned togetherLaw offices based in Los Angeles announce a lawsuit and use Twitter for updates.Moves Novocure (Jersey)
-
LinkedIn Mentioned togetherBoth LinkedIn and Google are currently being utilized as platforms for news distribution.Moves Novocure (Jersey)
Connections
The 6 strongest of 34, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Novocure submits therapeutic applications to the FDA for regulatory review and approval.
-
MPM Transactional
MPM generated $0.8 million in revenue from Optune Lua, a product related to Novocure, for treating malignant pleural mesothelioma.
-
LinkedIn Mentioned together
Novocure follows LinkedIn's professional profile on the platform.
-
Twitter Mentioned together
Novocure follows Twitter's account on social media.
-
Switzerland Shared context
Novocure's global headquarters is located in Switzerland.
-
Haifa Shared context
Novocure maintains research and development facilities located in Haifa.
History
Events by the month they beganJune 2026
5 events- Novocure established its global headquarters in Baar, Switzerland, and maintains research and development facilities in Haifa, Israel. The company also uses LinkedIn and Twitter for updates.
- Novocure's stock price was boosted by strong market conditions on June 30, 2025.
- Leerink partners reiterated a Buy rating on Novocure Limited, citing solid results regarding its Optune/TTFields therapy.
- Novocure submitted a PMA application for its proprietary TTFields therapy, Optune Lua, targeting pancreatic cancer.
- Novocure announced coverage in Spain, appointing a country manager and gaining availability through the Spanish Ministry of Health.